PARTIAL EPIGENETIC REPROGRAMMING FOR LIVER DISEASE TREATMENT
US20260108630A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name Life Biosciences, Inc..
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
US20260108630A1 · Application publication visible